Tyler Jacks
Director/Board Member presso THERMO FISHER SCIENTIFIC
Patrimonio netto: 9 M $ in data 29/02/2024
Profilo
Founder of T2 Biosystems, Inc. and Dragonfly Therapeutics, Inc., Tyler E.
Jacks currently is President & Director at Commonwealth Cancer Consortium, Inc. He is also on the board of Amgen, Inc. and Thermo Fisher Scientific, Inc. and Professor at Massachusetts Institute of Technology.
He previously held the position of Director at David H.
Koch Institute for Integrative Cancer Research and Chairman for National Cancer Institute.
He received an undergraduate degree from Harvard University and a doctorate from The University of California, San Francisco.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
24/05/2023 | 8 059 ( 0.00% ) | 5 M $ | 29/02/2024 | |
AMGEN INC.
0.00% | 19/05/2023 | 14 868 ( 0.00% ) | 4 M $ | 29/02/2024 |
Posizioni attive di Tyler Jacks
Società | Posizione | Inizio |
---|---|---|
THERMO FISHER SCIENTIFIC | Director/Board Member | 26/05/2009 |
AMGEN INC. | Director/Board Member | 01/01/2012 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2007 |
Commonwealth Cancer Consortium, Inc. | President | 01/02/2021 |
Precedenti posizioni note di Tyler Jacks
Società | Posizione | Fine |
---|---|---|
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2021 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Chairman | 01/01/2016 |
T2 BIOSYSTEMS, INC. | Founder | 01/01/2013 |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Founder | - |
Formazione di Tyler Jacks
Harvard University | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMGEN INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
T2 BIOSYSTEMS, INC. | Health Technology |
Aziende private | 4 |
---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Health Technology |
Commonwealth Cancer Consortium, Inc. |